[CLSTR]
< Back to situations

[ORGANIZATION]

Celltrion

Featured in 7 tracked stories · first seen

Situations

[QUIET] [BUSINESS] [KR] [HK] [MY]

Celltrion biosimilar market expansion

2 clusters · 2 sources · last updated

Latest: Celltrion secures leading market shares for biosimilars in Asia

Celltrion has demonstrated significant financial and market growth driven by its biosimilar portfolio. In its second-quarter 2025 results, the company reported sales of 1.3937 trillion won and an operating profit of 451.

[QUIET] [BUSINESS] [KR] [US]

Celltrion drug pipeline development

2 clusters · 3 sources · last updated

Latest: Celltrion ADC drug candidates receive FDA Fast Track designation

South Korean biotech firm Celltrion is advancing several drug development programs, specifically focusing on an obesity drug candidate, CT-G32, and a pipeline of antibody-drug conjugates (ADC) for cancer treatment. Rega

Also covered in